West Sweden Parkinson Objective Measurement Registry Study

NCT03130595 | Active Not Recruiting

• 2 other identifiers: WestPORTSPARKreg
• Study Type: observational
• Target: 320
• Locations: 1 country
• Sites: 1

Brief Summary

WestPORTS will recruit a randomly selected population consisting of 25% of all individuals with Parkinson's disease (ICD G209) that have visited any of the seven major outpatient neurology or geriatrics clinics in West Sweden (population 1.7M) during a predefined 12 month period between Sept 2016 and April 2018. Baseline clinical and demographic data will be collected along with a 6 x 24h accelerometry recording using the Parkinson Kinetigraph (Global Kinetics). Repeated data collections will be made with regular intervals of up to 2 years as long as subjects are alive and willing.

Conditions

Parkinson Disease; Parkinsonism; Parkinsonian Disorders

Keywords

accelerometry; Parkinson Kinetigraph

Outcome Measures

Primary Outcomes (1)

• Objective measurement of spontaneous movement patterns

  Parkinson Kinetigraph

  144 hours

Study Arms (1)

PD outpatients in West Sweden

Cross-sectional random sample of patients with PD that have visited outpatient clinics in West Sweden in the last 6+6 months

Eligibility Criteria

• Age: 20 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

25% of the population described by the inclusion criteria

You may qualify if:

• Medical record with a G209 (Parkinson's disease) diagnosis
• A visit to one of the participating outpatient clinics in West Sweden within the last 6 months
• Informed consent

You may not qualify if:

• Diagnosis revised before visit.

Sponsors & Collaborators

• Sahlgrenska University Hospital: lead
• Göteborg University: collaborator

Study Sites (1)

Sahlgrenska University Hospital

Gothenburg, 41345, Sweden

Location

MeSH Terms

Conditions

Parkinson Disease; Parkinsonian Disorders

Condition Hierarchy (Ancestors)

Basal Ganglia Diseases; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Movement Disorders; Synucleinopathies; Neurodegenerative Diseases

Study Officials

• Filip Bergquist, MD, PhD

  Göteborg University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: ECOLOGIC OR COMMUNITY
• Time Perspective: PROSPECTIVE
• Target Duration: 15 Years
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Associate Professor

Study Record Dates

• First Submitted: April 22, 2017
• First Posted: April 26, 2017
• Study Start: April 26, 2017
• Primary Completion: May 1, 2025
• Study Completion (Estimated): December 1, 2030
• Last Updated: November 27, 2024

Record last verified: 2024-11

Data Sharing

• IPD Sharing: Will share
• Shared Documents: STUDY PROTOCOL
• Time Frame: See plan description
• Access Criteria: Access to data requires ethical permission and permission from the registry scientific committee SWEPAR.

Locations

SE (1)